• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) NV MICROCATHETER; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) NV MICROCATHETER; CATHETER, CONTINUOUS FLUSH Back to Search Results
Device Problems Break (1069); Difficult to Remove (1528)
Patient Problem Foreign Body In Patient (2687)
Event Type  malfunction  
Manufacturer Narrative
The catheter was not returned, as it was reported to have been left within the patient.Attempts have been made to obtain additional information.However, our attempts have been unsuccessful.Based on the reported information, the report of entrapment could not be confirmed and the cause could not be determined.There is no evidence suggesting that the catheter was defective, but rather a procedure related event.Angioarchitecture, vasospasm, reflux, long catheter dwell time, or prolonged injection time may result in difficult catheter removal and potential entrapment.For this event, it is possible the reported excessive reflux or prolonged injection time contributed to the reported issue.All products are 100% inspected for damages and irregularities during manufacture.Per the reported information, the catheter that was used was either a marathon or echelon-10.We were unable to verify the which device was used.Per the liquid embolic material instructions for use (ifu): do not allow more than 1 cm of liquid embolic material to reflux back over catheter tip.Difficult catheter removal or catheter entrapment may be caused by one or more of the following factors: long catheterization time; angio-architecture: very distal arteriovenous malformation fed by afferent, lengthened, small, or tortuous pedicles; vasospasm; reflux; injection time.To reduce the risk of catheter entrapment, carefully select catheter placement and manage reflux to minimize the factors listed above.Linked events: 2029214-2017-00813 2029214-2017-00814.
 
Event Description
Citation: ¿results and complications of transarterial embolization of intracranial dural arteriovenous fistulas using onyx-18¿ xianli lv, m.D., chuhan jiang, m.D., youxiang li, m.D., j.Neurosurg./ volume 109 / december 2008 medtronic received report that 31 patients with intracranial dural arteriovenous fistulas davfs were treated with onyx 18.There were 10 women and 21 men, ranging in age from 23 to 60 years (mean 43 years).There was one case that was reported to have gluing of the microcatheter.This patient was a (b)(6) male that presented with intracerebral hemorrhage (ich).The davf was successfully treated and the patient was asymptomatic post intervention.The gluing of the microcatheter in 1 patient resulted from a long reflux and long injection time (25 minutes).The catheter was not removed from the patient.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NV MICROCATHETER
Type of Device
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9492753836
MDR Report Key6655684
MDR Text Key78188078
Report Number2029214-2017-00815
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/24/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/24/2017
Initial Date FDA Received06/20/2017
Supplement Dates Manufacturer Received05/24/2017
Supplement Dates FDA Received10/04/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability;
Patient Age23 YR
-
-